scispace - formally typeset
J

Jezabel Varadé

Researcher at Hospital Clínico San Carlos

Publications -  37
Citations -  1767

Jezabel Varadé is an academic researcher from Hospital Clínico San Carlos. The author has contributed to research in topics: Single-nucleotide polymorphism & Linkage disequilibrium. The author has an hindex of 20, co-authored 35 publications receiving 1619 citations. Previous affiliations of Jezabel Varadé include Complutense University of Madrid.

Papers
More filters
Journal ArticleDOI

Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease

Gosia Trynka, +63 more
- 01 Dec 2011 - 
TL;DR: The complex genetic architecture of the risk regions of and refine the risk signals for celiac disease are defined, providing the next step toward uncovering the causal mechanisms of the disease.
Journal ArticleDOI

Association of the STAT4 gene with increased susceptibility for some immune-mediated diseases.

TL;DR: The STAT4 gene is emerging as a novel common risk factor for diverse complex diseases, including inflammatory bowel disease, Crohn's disease and ulcerative colitis and type 1 diabetes mellitus.
Journal ArticleDOI

Chromosomal region 16p13: further evidence of increased predisposition to immune diseases

TL;DR: In this paper, the role of CLEC16A polymorphisms in T1D, MS and RA pathogenesis and its relationship with the association reported with a MHC2TA haplotype was tested.
Journal ArticleDOI

Role of the MHC2TA gene in autoimmune diseases

TL;DR: The MHC2TA gene influences predisposition to rheumatoid arthritis and multiple sclerosis, but not to IBD, and the −168G allele is not an aetiological variant in itself, but a genetic marker of susceptibility/protection haplotypes.
Journal ArticleDOI

Specific association of a CLEC16A/KIAA0350 polymorphism with NOD2/CARD15(-) Crohn's disease patients.

TL;DR: Analysis of association of CLEC16A/KIAA0350 polymorphisms with IBD patients and ethnically matched healthy controls suggests microbial recognition through different pathways seems to converge in the development of these polygenic bowel diseases.